Research ArticleOriginal Article
Open Access

Prevalence of COVID-19 antibodies among operating room and critical care staff at a tertiary teaching hospital

A cross-sectional study

Sara H. Farsi, Thamir A. Alandijany, Mansoor Radwi, Ali Farsi, Wadeeah Bahaaziq, Ibrahim Abushoshah, Sherif A. El-Kafrawy, Salma Alsayed, Esam I. Azhar and Abdulaziz Boker
Saudi Medical Journal July 2021, 42 (7) 742-749; DOI: https://doi.org/10.15537/smj.2021.42.7.20210348

References

  1. 1.↵
    World Health Organization. General’s opening remarks at the media briefing on COVID-19; March 11 2020 [cited Jan 17, 2021]. Available from: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020.
  2. 2.↵
    1. Liu Y,
    2. Gayle AA,
    3. Wilder-Smith A,
    4. Rocklöv J.
    The reproductive number of COVID-19 is higher compared to SARS coronavirus. J Travel Med 2020; 27: 1–4.
    OpenUrlCrossRefPubMed
  3. 3.↵
    World Health Organization. Coronavirus disease (COVID-19) dashboard. [cited 2021]. Available from: https://covid19.who. int
  4. 4.↵
    1. Barrett ES,
    2. Horton DB,
    3. Roy J,
    4. Gennaro ML,
    5. Brooks A,
    6. Tischfield J, et al.
    Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers at the onset of the U.S. COVID-19 epidemic. medRxiv 2020;
  5. 5.
    CDC COVID-19 Response Team. Characteristics of health care personnel with COVID-19 - United States, February 12-April 9, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 477-481.
  6. 6.↵
    1. Hughes MM,
    2. Groenewold MR,
    3. Lessem SE,
    4. Xu K,
    5. Ussery EN,
    6. Wiegand RE, et al.
    Update: characteristics of health care personnel with COVID-19 - United States, February 12-July 16, 2020. MMWR Morb Mortal Wkly Rep 2020; 69: 1364–1368.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Li R,
    2. Rivers C,
    3. Tan Q,
    4. Murray MB,
    5. Toner E,
    6. Lipsitch M.
    The demand for inpatient and ICU beds for COVID-19 in the US: lessons from Chinese cities. medRxiv 2020. doi: 10.1101/2020.03.09.20033241
  8. 8.
    1. Cohen J,
    2. Rodgers YVM.
    Contributing factors to personal protective equipment shortages during the COVID-19 pandemic. Prev Med 2020; 141: 106263.
    OpenUrlPubMed
  9. 9.↵
    1. Ahmed J,
    2. Malik F,
    3. Bin Arif T,
    4. Majid Z,
    5. Chaudhary MA,
    6. Ahmad J, et al.
    Availability of personal protective equipment (PPE) among US and Pakistani doctors in COVID-19 pandemic. Cureus 2020; 12: e8550.
    OpenUrl
  10. 10.↵
    1. Zhou Q,
    2. Gao Y,
    3. Wang X,
    4. Liu R,
    5. Du P,
    6. Wang X, et al.
    Nosocomial infections among patients with COVID-19, SARS and MERS: a rapid review and meta-analysis. Ann Transl Med. 2020; 8: 629.
    OpenUrl
  11. 11.
    1. Rhee C,
    2. Baker M,
    3. Vaidya V,
    4. Tucker R,
    5. Resnick A,
    6. Morris CA, et al.
    Incidence of nosocomial COVID-19 in patients hospitalized at a large US Academic Medical Center. JAMA Netw Open 2020; 3: e2020498.
    OpenUrl
  12. 12.↵
    1. Rickman HM,
    2. Rampling T,
    3. Shaw K,
    4. Martinez-Garcia G,
    5. Hail L,
    6. Coen P, et al.
    Nosocomial transmission of COVID-19: a retrospective study of 66 hospital-acquired cases in a London teaching hospital. Clin Infect Dis 2020; 72: 690–693.
    OpenUrl
  13. 13.↵
    1. Chatterjee P,
    2. Nagi N,
    3. Agarwal A,
    4. Das B,
    5. Banerjee S,
    6. Sarkar S, et al.
    The 2019 novel coronavirus disease (COVID-19) pandemic: a review of the current evidence. Indian J Med Res 2020; 151: 147–59.
    OpenUrl
  14. 14.↵
    1. Huff HV,
    2. Singh A.
    Asymptomatic transmission during the COVID-19 pandemic and implications for public health strategies. Clin Infect Dis 2020; 71: 2752–2756.
    OpenUrl
  15. 15.↵
    1. Ganyani T,
    2. Kremer C,
    3. Chen D,
    4. Torneri A,
    5. Faes C,
    6. Wallinga J, et al.
    Estimating the generation interval for coronavirus disease (COVID-19) based on symptom onset data, March 2020. EURO Surveill 2020; 25. ES.2020.25.17.2000257.
  16. 16.↵
    1. Rivett L,
    2. Sridhar S,
    3. Sparkes D,
    4. Routledge M,
    5. Jones NK,
    6. Forrest S, et al.
    Screening of healthcare workers for SARS-CoV-2 highlights the role of asymptomatic carriage in COVID-19 transmission. eLife 2020; 9: e58728.
    OpenUrlCrossRefPubMed
  17. 17.↵
    1. Galanis P,
    2. Vraka I,
    3. Fragkou D,
    4. Bilali A,
    5. Kaitelidou D.
    Seroprevalence of SARS-CoV-2 antibodies and associated factors in health care workers: a systematic review and meta-analysis. J Hosp Infect 2020; 108: 120–134.
    OpenUrl
  18. 18.↵
    1. Schwartz J,
    2. King CC,
    3. Yen MY.
    Protecting healthcare workers during the coronavirus Disease 2019 (COVID-19) outbreak: lessons from Taiwan’s severe acute respiratory syndrome response. Clin Infect Dis 2020; 71: 858–860.
    OpenUrlPubMed
  19. 19.↵
    1. Alandijany TA,
    2. El-Kafrawy SA,
    3. Tolah AM,
    4. Sohrab SS,
    5. Faizo AA,
    6. Hassan AM, et al.
    Development and optimization of in-house ELISA for detection of human IgG antibody to SARS-CoV-2 full length spike protein. Pathogens 2020; 9: 803.
    OpenUrl
  20. 20.↵
    1. Fukuda H,
    2. Seyama K,
    3. Ito K,
    4. Hori S,
    5. Wakita M,
    6. Saito K, et al.
    SARS-CoV-2 seroprevalence in healthcare workers at a frontline hospital in Tokyo. Research Square 2020. doi: 10.21203/rs.3.rs-96870/v1
  21. 21.↵
    1. Shields A,
    2. Faustini SE,
    3. Perez-Toledo M,
    4. Jossi S,
    5. Aldera E,
    6. Allen JD, et al.
    SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study. Thorax 2020; 75: 1089–1094.
    OpenUrlAbstract/FREE Full Text
  22. 22.
    1. Moscola J,
    2. Sembajwe G,
    3. Jarrett M,
    4. Farber B,
    5. Chang T,
    6. McGinn T, et al.
    Prevalence of SARS-CoV-2 antibodies in health care personnel in the New York City Area. JAMA 2020; 324: 893–895.
    OpenUrlPubMed
  23. 23.↵
    1. Fernández-Rivas G,
    2. Quirant-Sánchez B,
    3. González V,
    4. Doladé M,
    5. Martinez-Caceres E,
    6. Piña M, et al.
    Seroprevalence of SARS-CoV-2 IgG specific antibodies among healthcare workers in the northern metropolitan area of Barcelona, Spain, after the first pandemic wave. medRxiv 2020; 06: 20135673.
  24. 24.↵
    1. Gralton J,
    2. McLaws ML.
    Protecting healthcare workers from pandemic influenza: N95 or surgical masks? Crit Care Med 2010; 38: 657–667.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Alandijany TA,
    2. Faizo AA,
    3. Azhar EI.
    Coronavirus disease of 2019 (COVID-19) in the Gulf Cooperation Council (GCC) countries: current status and management practices. J Infect Public Health 2020; 13: 839–842.
    OpenUrlPubMed
  26. 26.↵
    1. Naar I.
    Timeline: here are all the measures taken by Saudi Arabia to combat the coronavirus; 2020, May 20. Al Arabiya English [cited 2021 Jan 17]. Available from: https://english.alarabiya.net/en/features/2020/03/28/Timeline-Saudi-Arabias-proactive-measures-to-combat-the-COVID-19-coronavirus.
  27. 27.↵
    COVID 19 dashboard: Saudi Arabia. Ministry of Health [cited 2021 Jan 17]. Available from: https://covid19.moh.gov.sa.
  28. 28.↵
    1. Treibel TA,
    2. Manisty C,
    3. Burton M,
    4. McKnight Á,
    5. Lambourne J,
    6. Augusto JB, et al.
    COVID-19: PCR screening of asymptomatic health-care workers at London hospital. Lancet 2020; 395: 1608–1610.
    OpenUrlCrossRefPubMed
  29. 29.↵
    1. Long QX,
    2. Tang XJ,
    3. Shi QL,
    4. Li Q,
    5. Deng HJ,
    6. Yuan J, et al.
    Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020; 26: 1200–1204.
    OpenUrlCrossRefPubMed
  30. 30.↵
    1. McAloon C,
    2. Collins Á,
    3. Hunt K,
    4. Barber A,
    5. Byrne AW,
    6. Butler F, et al.
    Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research. BMJ Open 2020; 10: e039652.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. Arevalo-Rodriguez I,
    2. Buitrago-Garcia D,
    3. Simancas-Racines D,
    4. Zambrano-Achig P,
    5. Del Campo R,
    6. Ciapponi A, et al
    . False-negative results of initial RT-PCR assays for COVID-19: A systematic review. PLoS One 2020; 15: e0242958.
  32. 32.↵
    1. Figueiredo-Campos P,
    2. Blankenhaus B,
    3. Mota C,
    4. Gomes A,
    5. Serrano M,
    6. Ariotti S, et al.
    Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset. Eur J Immunol 2020; 50: 2025–2040.
    OpenUrlCrossRefPubMed
  33. 33.↵
    1. Fan Q,
    2. Zhang W,
    3. Li B,
    4. Li DJ,
    5. Zhang J,
    6. Zhao F.
    Association Between ABO Blood Group system and COVID-19 susceptibility in wuhan. Front Cell Infect Microbiol 2020; 10: 404.
    OpenUrl
  34. 34.
    1. Zhao J,
    2. Yang Y,
    3. Huang H,
    4. Li D,
    5. Gu D,
    6. Lu X, et al.
    Relationship between the ABO blood group and the COVID-19 susceptibility. Clin Infect Dis 2020; 4: ciaa1150.
  35. 35.↵
    1. Cheng Y,
    2. Cheng G,
    3. Chui CH,
    4. Lau FY,
    5. Chan PK,
    6. Ng MH, et al.
    ABO blood group and susceptibility to severe acute respiratory syndrome. JAMA 2005; 293: 1450–1451.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Guillon P,
    2. Clément M,
    3. Sébille V,
    4. Rivain JG,
    5. Chou CF,
    6. Ruvoën-Clouet N, et al.
    Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology 2008; 18: 1085–1093.
    OpenUrlCrossRefPubMed
  37. 37.↵
    1. Long QX,
    2. Liu BZ,
    3. Deng HJ,
    4. Wu GC,
    5. Deng K,
    6. Chen YK, et al.
    Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 2020; 26: 845–848.
    OpenUrlPubMed
  38. 38.
    1. To KK-W,
    2. Cheng VC-C,
    3. Cai JP,
    4. Chan KH,
    5. Chen LL,
    6. Wong LH, et al.
    Seroprevalence of SARS-CoV-2 in Hong Kong and in residents evacuated from Hubei Province, China: a multicohort study. The Microbe 2020; 1: e111–e118.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section

Keywords